Table 4. Matricellular protein levels in tracheal aspirates of babies who developed BPD or died before 36 weeks postmenstural age (BPD/death) and the ones who did not develop BPD (No BPD).
For each group, the number of samples, N, analyzed for each matricellular protein is shown.
| No BPD | N | BPD/death | N | P-value | |
|---|---|---|---|---|---|
| SPARC (ng/ml) | 85.30 (177.3) | 28 | 206.0 (395.5) | 45 | 0.03 |
| Gal1 (ng/ml) | 10.20 (17.13) | 24 | 11.96 (30.72) | 42 | 0.61 |
| THBS1 (ng/ml) | 7.300 (9.910) | 14 | 5.290 (14.72) | 44 | 0.45 |
| Periostin (ng/ml) | 3.760 (2.712) | 28 | 3.570 (5.210) | 45 | 0.82 |
| TGFBI (ng/ml) | 121.9 (203.3) | 23 | 70.03 (187.9) | 44 | 0.33 |
| Cyr61 (pg/ml) | 1290 (1633) | 26 | 944.9 (1578) | 44 | 0.60 |
| CTGF (ng/ml) | 0.2011 (0.2821) | 11 | 0.2039 (0.4154) | 11 | 0.65 |
Data are median (interquartile range). Comparisons were performed using the Mann-Whitney U test.